Skip to main content
. Author manuscript; available in PMC: 2009 Sep 17.
Published in final edited form as: J Pharmacol Exp Ther. 2008 Sep 4;327(3):941–953. doi: 10.1124/jpet.108.140350

Fig. 8.

Fig. 8

Pharmacokinetic profiling of VU0152099 and VU0152100 in rats. Concentration-time profile of VU0152099 (A) and VU0152100 (B) in brain and plasma of male Sprague-Dawley rats following a 56.6 mg/kg i.p. administration of each compound. Blood and brain tissue were collected at 0.5, 1, 2, and 4 h after injection. Samples were extracted as described under Materials and Methods and analyzed by LC-MS-MS. Each time point represents the mean determination ± S.E.M. of three rats.